Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 300 of 593 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/01/12
End: 11/25/20
Due: 11/25/21
Phase: N/A
Priority: Normal
Start: 06/30/01
End: 06/30/02
Due: 06/30/03
Phase: N/A
Priority: Normal
Start: 09/15/11
End: 05/20/19
Due: 05/20/20
Phase: N/A
Priority: Normal
Start: 12/31/98
End: 12/31/02
Due: 12/31/03
Phase: N/A
Priority: Normal
Start: 03/31/99
End: 07/31/00
Due: 07/31/01
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 07/31/02
Due: 07/31/03
Phase: N/A
Priority: Normal
Start: -
End: 07/31/03
Due: 07/31/04
Phase: N/A
Priority: Normal
Start: 08/08/06
End: 05/26/10
Due: 05/26/11
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
Phase: N/A
Priority: Normal
Start: 09/02/25
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 12/01/11
End: 08/03/15
Due: 08/03/16
Phase: N/A
Priority: Normal
Start: 10/31/01
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 01/31/97
End: 01/31/02
Due: 01/31/03
Phase: N/A
Priority: Normal
Start: 01/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/04/13
End: 02/03/15
Due: 02/03/16
Phase: N/A
Priority: Normal
Start: 12/04/96
End: 09/07/11
Due: 09/07/12
Phase: N/A
Priority: Normal
Start: 12/31/01
End: 12/31/04
Due: 12/31/05
Phase: N/A
Priority: Normal
Start: 04/30/92
End: 06/30/04
Due: 06/30/05
Phase: N/A
Priority: Normal
Start: 12/23/14
End: 09/27/19
Due: 09/27/20
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 01/31/99
End: 07/31/02
Due: 07/31/03
Phase: N/A
Priority: Normal
Start: 10/26/13
End: 06/20/18
Due: 06/20/19
Phase: N/A
Priority: Normal
Start: 01/31/03
End: 01/31/07
Due: 01/31/08
Phase: N/A
Priority: Normal
Start: 05/07/03
End: 12/29/11
Due: 12/29/12
Phase: N/A
Priority: Normal
Start: 05/18/08
End: 02/25/10
Due: 02/25/11